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Abstract 
Purpose: To investigate the prevalence of cobalamin and folate deficiencies among the elderly in the 
general population of Shiraz in southern Iran. 
Methods: This is a descriptive cross-sectional study including 340 individuals who are over 50 years old 
and were selected randomly from all the regions of Shiraz.  
Results: The study group was made up of 132 (38.8 %) males and 208 (61.2 %) females. In this group 
174 (51.2 %) were aged 50 - 59 years and 166 (48.8 %) were aged ≥ 60 years. Cobalamin deficiency (< 
200 pg/mL) was present in 124 (36.2 %) while 42 (12.4 %) had severe deficiency with levels < 100 
pg/mL. Signs of metabolic deficiency at the cellular level were seen in 21 (5.25 %) of the samples. 
Serum folate deficiency (< 4 ng/mL) was present in 134 (39.4 %) while 19 (5.6 %) persons had severe 
folate deficiency (≤ 2 - 3 ng/mL). Correlation analysis showed that serum cobalamin and homocysteine 
in the study samples were not significant (p > 0.05). 
Conclusion: The prevalence of severe cobalamin deficiency with clinical significance is high in the 
elderly population of Shiraz, Iran.  
 
Keywords: Vitamin B12 deficiency, Folate deficiency, Homocysteinemia, Elderly population 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Vitamin B12 (Cobalamin) is a water-soluble 
vitamin. Its main role in the body is to transfer 
methyl groups. Cobalamin is needed for two 
actions; one of them is conversion of methyl 
malonyl co-A to succinyl co-A and the other is 
conversion of homocysteine to methyonin [1]. 
Vitamin B12 deficiency occurs with atrophic 
gastritis, intestinal malabsorption, pancreatic 
insufficiency, decreased intake, consumption of 
some drugs, inborn errors, transcobalamin l 
deficiency and errors of cobalamin metabolism 
[1].  
 
Elderly people are at increased risk of B12 
deficiency, due to the risk of both reduced intake 
and decreased absorption [2-5]. In this context, 
serum B12 monitoring has been suggested for 
the elderly [6]. Vitamin B12 deficiency has no 
specific sign and symptom, but this disease can 
have indicators such as anemia, 
psychoneurologic symptoms, parasthesia, 
sensory loss and dementia [7-11]. Cobalamin 
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deficiency may increase serum homocysteine 
[12].  
 
High amount of homocysteine have been 
correlated with increased risk of cardiovascular 
disease especially in elderly [13]. 
Homocysteinemia may be caused by several 
nutritional deficiencies other than B12, including 
vitamin B6 and folate deficiencies [14]. 
Depending on the cutoff levels, previous studies 
have reported the prevalence of vitamin B12 
deficiency to be between 10 to 43 % [15-18]. 
When serum level < 200 pg/mL was used as cut 
off, 10 – 15 % of old people had vitamin B12 
deficiency [21].  
 
There are limited data on serum folate, vitamin 
B12 and homocysteine levels in the Islamic 
Republic of Iran. In the population, the 
consumption of all types of vegetables is high but 
meat consumption is lower than in western 
countries. In a survey conducted on the low 
income population in South West region of 
Tehran, Iran, age-adjusted incidences of low 
serum cobalamin was 27.2 % in females and 
26.32 % in males. Moreover, low serum folate 
level was 97.92 % in females and 98.67 % in 
males [15,16].  
 
Folate deficiency can cause macrocytic anemia 
(low red blood cell count), and low levels of white 
blood cells and platelets in severe cases but may 
also show neural features that are different from 
those of vitamin B12 deficiency. Most people get 
enough folate from food. Inadequate folate status 
is highly prevalent in the adult population, while 
vitamin B12 status in young adults is generally 
sufficient. Nevertheless, older people often show 
vitamin B12 deficiency, and hence cobalamin 
supplementation may play a major role in 
lowering homocysteine levels in this group [6,22]. 
The aim of the present study was to determine 
the prevalence of vitamin B12 and folate 
deficiencies,  and their possible association with 
each other and with homocysteine levels  in over 




Study population  
 
Shiraz is a large metropolitan city in southern 
Iran with a population of 1,460,665, according to 
2011 census. A weighted cluster random 
sampling technique was used to gather the 
samples from all the regions of Shiraz, based on 
the population of municipality data. Those aged ≥ 
50 years, who were apparently healthy and not 
on any medication were invited to participate by 
some health members of staff that were referred 
to their houses. Those who agreed to participate 
were informed about the study and signed a 
consent form. They were referred to Namazi 
hospital after 12 h of fasting in the morning 
where a physician took their complete medical 
history and performed physical examination. A 
five milliter blood sample was collected from 
those who were found to be healthy. The serum 
was separated within one hour after sampling 





All the samples were tested at the same time (in 
one day) for Cobalamin, homocysteine and 
Folate. Cobalamin and Folate were measured by 
Radioisotope dilution using Simult RAC-SNB kit 
(ICN Co, USA); homocysteine was measured by 
ELISA (DRG Co, USA). Those samples that 
were used for calibration were consistent with 
their companies (IDEAL TASHKHIS Co, Iran). 
 
Determination of cobalamin, folate and 
homocysteine status 
 
Cutoff levels of < 200 pg/mL for cobalamin 
deficiency and < 100 pg/mL for severe 
deficiencies were used. Folate deficiency that 
was defined as serum levels below 4 ng/mL and 
2.3 ng/mL was considered severe deficiency. 
Homocysteine deficiency was defined as serum 
levels > 15 µmol/l and < 21.3 µmol/l was 
considered severe deficiency. Homocysteine 
serum level of > 21.3 µmol/L was considered 




The results are presented as mean ± SD and the 
percentage based on sex and age group were 
used to express the prevalence of variable blood 
factors. In the statistical analysis of the 
relationship between variables, T-test and 
Pearson correlation were used. The data were 
analyzed using SPSS 18 software, and p < 0.05 




Three hundred and forty people aged ≥ 50 years 
including 132 males (38.8 %) and 208 females 
(61.2 %) participated in this study. In this group 
174 (51.2 %) were aged between 50-59 years 
and 166 (48.8 %) were aged 60 years or above 
(Table 1). 
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Table 1: Demographic characteristics of samples 
 
Age group Number (%) Gender Total 






% in group 














>60 years Number 
% in group 














% in group 











Prevalence of cobalamin deficiency  
 
In this study, the mean amount of cobalamin 
serum level in all samples was 386.6 ± 46 pg/mL, 
with a range from 0 to 1886 pg/mL. Figure 1 
demonstrates the distribution of samples on the 
basis of serum cobalamin. In most of the 
samples cobalamin serum level was below 300 
pg/mL (in 189 samples which equals more than 
55 %), and in 205 (60.2 %) of the samples 
cobalamin serum level was below the normal 
mean (350 pg/mL). 
 
124 people (36.4 %) had their cobalamin level < 
200pg/ml, and 42 (12.3%) had severe cobalamin 
deficiency with cobalamin level < 100 pg/mL. Of 
those with severe deficiency, 29 (69.04 %) were 
females and 13 (30.96) of males (Figure 2). 
 
 
Figure 1: Frequency distribution of the samples based on Cobalamin (pg/mL) (Key: Acceptable, ˃ 200 pg/mL; 




Figure 2: Frequency distribution of the samples based on cobalamin by gender (pg/ml) 
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In the 50 - 59 years age group, cobalamin serum 
level below 200 pg/mL was seen in 67 persons 
and severe cobalamin deficiency was present in 
23 persons. The figures for those aged ≥ 60 
years were 57 and 19 persons. 
 
The number of people whose cobalamin levels 
were less than the normal mean ± SD (300 
pg/mL) was 70 (20.6 %). Of these, 35 (20.1 %) 
persons were aged 50 – 59 years and 35 (21.1 
%) were > 60 years old (Figure 2). 
 
Prevalence of folate deficiency and 
homocysteine 
 
The mean serum level of folate was 5.8 ± 
3.02ng/mL (mean ± SD), ranging from 0 to 18.1 
ng/mL. Table 4 shows the findings related to 
serum level of folate according to age and 
gender groups. The mean serum level of folate in 
people aged 50 - 59 years was 5.4 ng/mL, with 
5.29 ng/mL in males and 6.2 ng/mL in females of 
this age group. 
 
The value in those ≥ 60 years old was 5.83 
ng/mL, with 5.95 ng/mL in males and 5.74 ng/mL 
in females. 
 
According to the statistical comparison, there 
were no significant differences between this 
numbers (p > 0.05). 
 
Based on the definition of serum folate deficiency 
19 (5.6 %) persons had severe folate deficiency 
and the folate serum level of 134 (39.4 %) 




The mean serum level of homocysteine was 15.2 
µmol/L with a range from 4.5 µmol/L up to 50.3 
µmol/L (Table 4). 
 
Table 4: Indicators of homocysteine, folate, and homocysteine serum level variables, by sex and age group 
 
Gender Age groups 
(number of 
samples) 
















6.9 50.3 18.3 1.2 9.06 












4.5 47.2 15.47 0.78 6.83 























4.6 30.2 13.4 0.45 4.28 
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The findings shows that the prevalence of 
cobalamin serum level below 200 pg/mL was 
36.47 %, while severe cobalamin deficiency with 
clinical significant was 12.35 %. This results in 
different countries with regard to race and ethnic 
differences are varies. It had been reported from 
4 to 55 %. [23,24]. However, most studies have 
reported the prevalence to be between 10 and 30 
% depending on the criteria used [25].  
 
A study on the elderly population of northeastern 
Iran showed that the prevalence of cobalamin 
deficiency with low levels (< 122 pg/mL) was 
22.7 % and with borderline levels (122 - 330 
pg/mL) was 51.8 % [15]. But, what is striking in 
this study is the high prevalence of cobalamin 
deficiency in the population under study. Also, 
the prevalence of cobalamin deficiency according 
to the cobalamin serum level below 200 ng/mL 
was 33.1 % in females and 41.6 % in males, of 
which our results were similar to those of the 
other studies, the prevalence of cobalamin 
deficiency in males was more than females [23]. 
But severe vitamin B12 deficiency in females 
was 13.9 % and was 9.8 % in males, therefore, 
the percentage of severe deficiency is higher in 
females. The present study was similar to 
another study, where the results showed that, the 
prevalence of cobalamin deficiency weren’t 
based on age groups but rather were gender 
statistically significant [23] 
 
In this study 5.25 % of the study samples had 
problems in cellular metabolism, and this number 
is similar to Faringham’s study results [23]. 
Taking into account that clinical signs are very 
different in cases with cobalamin deficiency, in 
some cases where the cobalamin serum levels 
were very low, there were no sign of deficiency 
[26], and sometimes in some people with 
cobalamin serum levels that are a little below 
normal, we can see neurological signs. 
Therefore, serum level itself cannot determine 
the severity of the disease [24,25,27-30]. 
However, serum levels < 100 pg/mL is clinically 
significant.  
 
The mean level for serum cobalamin was 383.6 ± 
46 pg/mL which was higher than the normal 
mean in other studies [23]. There is a possibility 
that it was due to the high percentage of people 
having higher serum cobalamin 900 pg/mL 
(about 10.2 % of the sample). There are a few 
published studies that have reported serum 
folate in Iranians. Based on the results, 5.65 % of 
the people had serum folate deficiency (< 2.3 
ng/mL), and severe folate deficiency (below 4 
ng/mL) was in 39.4 % of them. This it is almost 
similar to the results of a study that was 
conducted in Tehran on 1214 healthy persons 
[15].  
 
The mean of homocysteine serum level in our 
study was 15.1 µmol/L ± 3.6, which is higher 
than other populations (5 - 15 µmol/L). A 
possible reason could be that the samples in our 
study were for those older > 50 years, while in 
other studies they were < 55 years or for all ages 
[31,32]. It may be that the mean serum level of 
homocysteine in our society for some other 
reasons is really higher than others [23,32].  
 
On the other hand, the statistical comparison 
showed there were no significant correlation 
between cobalamin serum level and 
homocysteine serum level in our samples, and 
this result differs from the study done by Vakili et 
al [6]. It may be that this lack of significant 
correlation relates to the difference in the levels 
of B6 and folate level in both this and the other 
studies [6]. Also, correlation analysis showed that 
generally, homocysteine and folate serum level 
were indirectly correlated, and this funding was 
similar other studies [6,23]. An important problem 
encountered when comparing the prevalence of 
the levels of organic compounds based on 
studies is the variation of cut-offs point used to 
define shortage. In order to make results 
comparable, criteria and standards should be 
defined.  Hence, the re-definition of criteria and 




The results of this study show that the 
prevalence of cobalamin deficiency in the study 
population is high. Steps and some strategies, 
such as administering folic acid and vitamin B12 
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